• BlackRock trimmed its total stake in Fresenius Medical Care to 7.05% from 7.04%, based on a threshold crossing dated June 17, 2026.
• Voting rights attached to shares slipped to 5% from 5.02%.
• Voting rights through instruments rose to 2.05% from 2.02%, led by 0.63% in lent securities and 1.42% in contracts for difference.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. FMC - Fresenius Medical Care AG published the original content used to generate this news brief via EQS News (Ref. ID: PVR_2350936_en) on June 22, 2026, and is solely responsible for the information contained therein.